Opioid crackdowns on high-volume prescribers are proving more effective than previously understood. Between 1997 and 2011, opioid dispensing in the United States more than tripled. As a result, this surge laid the groundwork for America’s deadliest drug epidemic. Furthermore, a troubling pattern emerged from the data. Specifically, just 1 per cent of prescribing doctors were responsible for nearly 50 per cent of all domestic opioid doses.

The Concentration Problem In Opioid Supply

This extreme concentration of supply raised a critical question. Could targeted enforcement against these high-volume prescribers disrupt the flow of prescription drugs into communities? Ultimately, the answer appears to be yes, though with important caveats.

How Targeted Enforcement Against Opioid Suppliers Actually Works

New research in the American Economic Journal: Economic Policy provides compelling evidence about focused intervention strategies. Notably, Adam Soliman examined what happened when federal authorities conducted opioid crackdowns on doctors who overprescribed controlled substances. In fact, removing a single rogue doctor from the supply chain reduced county-level dispensing by approximately 10 per cent.

Long-Term Supply Disruption Through Crackdowns

Remarkably, this decline persisted across geographical boundaries. Moreover, it grew stronger over time. In other words, targeted enforcement doesn’t simply relocate the problem. Instead, it genuinely disrupts supply networks. By contrast, traditional drug enforcement efforts often see dealers and suppliers move to adjacent territories. However, these interventions showed no evidence of such displacement.

The Heroin Substitution Problem Following Enforcement

Nevertheless, opioid crackdowns came with significant trade-offs. On one hand, overall drug mortality declined following these interventions. On the other hand, heroin overdoses increased by 50 per cent. Consequently, existing users, unable to access prescription opioids, sought alternatives in the illicit market.

Doctors Versus Pharmacies In Targeted Enforcement

Interestingly, the distinction between doctors and pharmacies proved instructive. For instance, when authorities targeted pharmacies, local dispensing decreased. Meanwhile, nearby areas experienced increased supply as operations shifted location. In comparison, this resembled traditional drug enforcement patterns more closely. According to former DEA officials, overprescribing doctors operate as lone wolves. In contrast, pharmacies often function as part of larger criminal networks.

Economic Impact Of Opioid Crackdowns

The research uncovered economic dynamics following opioid crackdowns. Specifically, areas experiencing declines in legal supply saw prices for diverted pills on black markets increase by 30 to 40 per cent. Therefore, this price response confirms that enforcement genuinely restricted availability. In essence, it wasn’t merely redistributing supply.

Mortality Trade-Offs In Enforcement Strategies

Furthermore, mortality records revealed the complex outcomes of targeted enforcement. Indeed, they serve as the best nationwide proxy for drug use patterns. Importantly, for each additional heroin overdose death, researchers found two fewer prescription opioid overdose deaths. Admittedly, some existing users transitioned to more dangerous substances. Nevertheless, the interventions successfully prevented new users from entering the pipeline of prescription opioid abuse.

The Scale Of Impact From Targeted Opioid Enforcement

The concentration of opioid prescribing amongst a small number of doctors created both the problem and the opportunity. Between 2006 and 2014, authorities conducted approximately 200 interventions against doctors. Consequently, compared to the vast number of prescribing physicians nationwide, each action carried outsized importance.

Financial Benefits Of Supply Side Crackdowns

Notably, the average net benefit per intervention reached nearly £23 million for a given county. In addition, even accounting for the unintended heroin substitution, opioid crackdowns delivered substantial public health benefits. Subsequently, this cost effectiveness stemmed from the highly concentrated nature of problematic prescribing. Clearly, the numbers tell a compelling story about return on investment.

Balancing Supply Side Enforcement And Treatment Access

The Drug Enforcement Administration faces a delicate balancing act in the controlled substance market. On the one hand, prescription opioids serve legitimate medical needs for patients experiencing severe pain. On the other hand, their addictive properties create substantial risks of diversion into black markets. In fact, approximately 80 per cent of all diversion within the controlled substance market originates from doctors and pharmacies.

Smart Targeting In Supply Reduction Crackdowns

Furthermore, the research highlights how targeted enforcement can reduce diversion whilst limiting unintended consequences. For example, broad crackdowns might restrict access for legitimate patients. By comparison, focusing on the small percentage of high-volume prescribers allows authorities to address the greatest sources of problematic supply. Therefore, this precision matters for patient care.

Policy Lessons From Opioid Enforcement History

The opioid epidemic evolved through distinct phases. Initially, the prescription opioid wave lasted from the late 1990s until 2010. Subsequently, a transition to heroin followed. Then, synthetic opioids like fentanyl emerged from 2013 onwards. As a result, understanding what worked during the prescription phase offers valuable insights for addressing ongoing challenges.

Supply Side Versus Demand Side Approaches In Enforcement

Traditionally, the United States has relied heavily on supply side interventions to combat drug abuse. Moreover, the effectiveness of opioid crackdowns against concentrated suppliers suggests this approach can succeed when properly targeted. However, the heroin substitution effect underscores the need for complementary demand side measures.

Expanding Treatment Access Alongside Targeted Enforcement

Additionally, expanded treatment access could address the vulnerability of existing users. Otherwise, they might turn to more dangerous alternatives when prescription supplies tighten. Therefore, integrating targeted enforcement with robust treatment programmes may offer the optimal strategy. Overall, this combination reduces harm more effectively.

The Path Forward For Opioid Enforcement Strategies

Importantly, experts emphasise that enforcement measures must work alongside comprehensive treatment programmes. Indeed, the crisis demands this integrated approach. According to the National Academies of Sciences, Engineering, and Medicine, “a strictly enforced supply reduction strategy may cause substantial harms to individuals with OUD (and to society) unless treatment opportunities are aggressively increased” (NCBI Bookshelf, 2017). Similarly, the Center for American Progress notes that “policymakers at all levels of government must continue to address the opioid epidemic as a public health crisis by expanding treatment for substance use disorder, in addition to domestic and international enforcement measures to tackle drug trafficking” (Center for American Progress, 2024). Consequently, these perspectives highlight the need for balanced strategies combining targeted enforcement with accessible treatment options.

What The Evidence Shows About Crackdowns

Overall, the evidence from opioid crackdowns offers both encouragement and caution. In particular, targeted enforcement against concentrated sources of supply can deliver substantial benefits. Specifically, it disrupts networks rather than merely displacing them. Furthermore, the persistence and growth of supply reductions over time demonstrates genuine market disruption.

The Sobering Reality Of Enforcement Limits

Nevertheless, the 50 per cent increase in heroin overdoses serves as a sobering reminder. Clearly, enforcement alone cannot solve complex public health crises. Therefore, each intervention must be evaluated for its direct effects. Additionally, we must also consider how it might reshape user behaviour and substance markets.

Opportunities And Limitations Of Targeted Enforcement

Undoubtedly, the concentration of problematic prescribing created an unusual opportunity for effective intervention. However, few drug markets exhibit such extreme concentration amongst suppliers. Consequently, this makes the transferability of these lessons to other contexts uncertain. Nevertheless, the principle remains sound. Ultimately, identifying and targeting the most significant sources of harmful supply can yield disproportionate benefits.

A Balanced Approach Going Forward With Crackdowns

For communities grappling with substance abuse epidemics, the research offers clear guidance. Specifically, carefully designed opioid crackdowns work best alongside comprehensive treatment options. In turn, they can reduce both the supply of problematic substances and the overall harm they cause. However, the challenge lies in maintaining this balanced approach. Furthermore, authorities must remain responsive to how users and markets adapt to enforcement pressure.

Source: aeaweb